Skip to main content
Camilla Graham, MD, Infectious Disease, Boston, MA

CamillaSGrahamMD

Infectious Disease • Boston, MA

Assistant Clinical Professor, Medicine, Beth Israel Deaconess Medical Center

Join to view full profile

Dr. Graham is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Graham's full profile

Already have an account?

  • Office

    330 Brookline Ave
    # Beth
    Boston, MA 02215
    Phone+1 617-632-7706

Education & Training

  • Beth Israel Deaconess Medical Center
    Beth Israel Deaconess Medical CenterFellowship, Infectious Disease, 1998 - 2001
  • Boston University Medical Center
    Boston University Medical CenterResidency, Internal Medicine, 1994 - 1997
  • MCP-Hahnemann College of Medicine
    MCP-Hahnemann College of MedicineClass of 1994

Certifications & Licensure

  • MA State Medical License
    MA State Medical License 1996 - 2025
  • Infectious Disease
    American Board of Internal Medicine Infectious Disease

Awards, Honors, & Recognition

  • Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2011

Publications & Presentations

PubMed

Press Mentions

  • PureTech Presents Research Highlighting Burden of Idiopathic Pulmonary Fibrosis and Use of a Bayesian Statistical Analysis for LYT-100 at CHEST 2024 Annual Meeting
    PureTech Presents Research Highlighting Burden of Idiopathic Pulmonary Fibrosis and Use of a Bayesian Statistical Analysis for LYT-100 at CHEST 2024 Annual MeetingOctober 10th, 2024
  • PureTech Presents Research Highlighting Burden of Idiopathic Pulmonary Fibrosis (IPF) and Use of a Bayesian Statistical Analysis for LYT-100 (Deupirfenidone) at CHEST 2024 Annual Meeting
    PureTech Presents Research Highlighting Burden of Idiopathic Pulmonary Fibrosis (IPF) and Use of a Bayesian Statistical Analysis for LYT-100 (Deupirfenidone) at CHEST 2024 Annual MeetingOctober 9th, 2024
  • Task Force Recommends Hepatitis B Screening for People at Increased Risk
    Task Force Recommends Hepatitis B Screening for People at Increased RiskFebruary 5th, 2021
  • Join now to see all

Grant Support

  • Cellular Immunity To Hepatitis C Virus In HIVNational Institute On Drug Abuse2001–2005

Dr. Camilla Graham, Dr. Camilla Graham, MD, Dr. C Graham, Dr. Camilla S Graham